Penn Radiology – Oncologic Imaging Essentials 2020

Quantity must be 1 or more

Session 1: Head and Neck

Viral-Induced Neoplasia of the Head and Neck	Laurie A. Loevner, MD
Laryngeal Cancer: What the Clinician Needs to Know	Laurie A. Loevner, MD
PET/CT in Head and Neck Cancer: Pearls and Pitfalls	Laurie A. Loevner, MD
TI-RADS and Thyroid Cancer Detection	Jill Langer, MD
Orbital Neoplasia Patterns of Spread	Laurie A. Loevner, MD
Robotics in Head and Neck Cancer: Emphasis on Oropharyngeal Cancer	Laurie A. Loevner, MD

Session 2: Body Imaging I: Abdomen and Prostate

Imaging of Upper GI Tract Tumors	Susan L. Summerton, MD
Imaging of GU Tract Malignancies	Susan L. Summerton, MD
Incidentalomas on Abdominal Imaging	Susan L. Summerton, MD
Prostate Cancer Update	Jill Langer, MD

Session 3: Breast

Digital Breast Tomosynthesis: Today and Tomorrow	Samantha P. Zuckerman, MD
Update on Screening MR – Not Just for BRCA Patients	Samantha P. Zuckerman, MD
Management of High Risk Breast Lesions	Samantha P. Zuckerman, MD
Imaging Special Populations	Samantha P. Zuckerman, MD
Challenging Cases in Breast Imaging	Samantha P. Zuckerman, MD

Session 4: Body Imaging II: GYN and Colonography

Non-Ovarian GYN Malignancy- What Role Does the Radiologist Play?	Jill Langer, MD
Ovarian Cancer Screening	Jill Langer, MD
Screening for Colon Cancer: Role of CT Colonograpy	Susan L. Summerton, MD
Pre- and Post-Operative Imaging of the Colon	Susan L. Summerton, MD

Session 5: Nuclear Medicine Indications and Applications

Accepted Indications for FDG PET/CT	Daniel A. Pryma, MD
Pearls and Pitfalls in FDG PET/CT	Daniel A. Pryma, MD
FDG PET/CT in Response Assessment: Solid Tumors, Lymphoma, and Immunotherapy	Daniel A. Pryma, MD
Beyond FDG: PET/CT with Ga-68 DOTATATE, F-18 Fluciclovine, and PSMA	Daniel A. Pryma, MD
The Role of Nuclear Medicine in Thyroid Disease	Daniel A. Pryma, MD
Challenging Nuclear Medicine Cases	Daniel A. Pryma, MD

Release Date: 4/15/20
CME Expiration: 4/14/23

Welcome Newcomer